Gain Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Gain Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.17 | $-0.21 | 19.1 % |
Jun 2024 | 2024-08-08 | $-0.42 | $-0.20 | -110.0 % |
Mar 2024 | 2024-05-14 | $-0.22 | $-0.29 | 24.1 % |
Dec 2023 | 2024-03-26 | $-0.29 | $-0.32 | 9.38 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $0 | $400.00K | -100.0 % |
Mar 2024 | 2024-05-14 | $0 | $30.00K | -100.0 % |
Dec 2023 | 2024-03-26 | $0 | $320.00K | -100.0 % |
Jun 2023 | 2023-08-10 | $0 | $1.01M | -100.0 % |
Gain Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Gain Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.17, which beat the estimate of $-0.21.
Gain Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which hit the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.